Owens & Minor, Inc. (NYSE:OMI) Receives Average Recommendation of “Reduce” from Brokerages

Owens & Minor, Inc. (NYSE:OMIGet Free Report) has been assigned a consensus recommendation of “Reduce” from the seven brokerages that are currently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a sell rating and three have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $6.35.

OMI has been the topic of a number of research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Owens & Minor in a research note on Wednesday, October 8th. Zacks Research downgraded Owens & Minor from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th.

View Our Latest Report on OMI

Hedge Funds Weigh In On Owens & Minor

Institutional investors and hedge funds have recently bought and sold shares of the stock. Royal Bank of Canada raised its stake in shares of Owens & Minor by 60.1% during the first quarter. Royal Bank of Canada now owns 83,565 shares of the company’s stock valued at $754,000 after purchasing an additional 31,368 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Owens & Minor by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 44,787 shares of the company’s stock valued at $404,000 after purchasing an additional 1,857 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Owens & Minor by 43.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 576,799 shares of the company’s stock worth $5,208,000 after buying an additional 175,866 shares during the period. Woodline Partners LP acquired a new position in Owens & Minor in the 1st quarter worth $613,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Owens & Minor by 11.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 243,826 shares of the company’s stock valued at $2,202,000 after buying an additional 24,065 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Price Performance

The firm has a 50 day moving average of $2.81 and a two-hundred day moving average of $4.55. The stock has a market cap of $223.92 million, a P/E ratio of -0.17 and a beta of 1.37. Owens & Minor has a 52-week low of $2.38 and a 52-week high of $15.54.

Owens & Minor (NYSE:OMIGet Free Report) last issued its earnings results on Thursday, October 30th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. Owens & Minor had a positive return on equity of 95.57% and a negative net margin of 19.99%.The business had revenue of $697.26 million during the quarter, compared to analysts’ expectations of $704.06 million. During the same quarter in the previous year, the business earned $0.36 EPS. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. As a group, equities analysts expect that Owens & Minor will post 1.51 earnings per share for the current year.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc is a global healthcare solutions company specializing in the distribution of medical and surgical supplies, as well as supply chain management services. The company partners with healthcare providers, manufacturers and group purchasing organizations to deliver critical products and customized logistics solutions across the continuum of care. Its offerings range from standard medical-surgical products to specialized clinical devices, all supported by technology-driven inventory management and consulting services aimed at optimizing operational efficiency for hospitals, ambulatory surgery centers and other care facilities.

Founded in 1882 and headquartered in Mechanicsville, Virginia, Owens & Minor has evolved from a regional pharmaceutical distributor into a leader in healthcare logistics.

Further Reading

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.